227 related articles for article (PubMed ID: 24380737)
21. Update in addiction medicine for the primary care clinician.
Gordon AJ; Fiellin DA; Friedmann PD; Gourevitch MN; Kraemer KL; Arnsten JH; Saitz R;
J Gen Intern Med; 2008 Dec; 23(12):2112-6. PubMed ID: 18830761
[No Abstract] [Full Text] [Related]
22. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
[TBL] [Abstract][Full Text] [Related]
23. Treatment consumption and treatment re-enrollment in GHB-dependent patients in The Netherlands.
van Noorden MS; Mol T; Wisselink J; Kuijpers W; Dijkstra BAG
Drug Alcohol Depend; 2017 Jul; 176():96-101. PubMed ID: 28531770
[TBL] [Abstract][Full Text] [Related]
24. Gamma-hydrobutyric acid (GHB) and its chemical modifications: a review of the GHBergic system.
Waszkielewicz A; Bojarski J
Pol J Pharmacol; 2004; 56(1):43-9. PubMed ID: 15047976
[TBL] [Abstract][Full Text] [Related]
25. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines.
Quang LS; Colombo G; Lobina C; Maccioni P; Orru A; Gessa GL; Maher TJ; Carai MA
Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952
[TBL] [Abstract][Full Text] [Related]
26. Influence of Gamma-Hydroxybutyric Acid-Use and Gamma-Hydroxybutyric Acid-Induced Coma on Affect and the Affective Network.
Raposo Pereira F; McMaster MTB; de Vries YDAT; Polderman N; van den Brink W; van Wingen GA
Eur Addict Res; 2019; 25(4):173-181. PubMed ID: 30999293
[TBL] [Abstract][Full Text] [Related]
27. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.
van Noorden MS; van Dongen LC; Zitman FG; Vergouwen TA
Gen Hosp Psychiatry; 2009; 31(4):394-6. PubMed ID: 19555805
[TBL] [Abstract][Full Text] [Related]
28. Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study.
Elsing C; Stremmel W; Grenda U; Herrmann T
Am J Drug Alcohol Abuse; 2009; 35(3):189-92. PubMed ID: 19462303
[TBL] [Abstract][Full Text] [Related]
29. [Gamma-hydroxybutyrat (GHB)-dependence and -withdrawal in the case of previous alcohol dependence].
Richter C; Romanowski A; Kienast T
Psychiatr Prax; 2009 Oct; 36(7):345-7. PubMed ID: 19173170
[TBL] [Abstract][Full Text] [Related]
30. An overview of gamma-hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results.
Andresen H; Aydin BE; Mueller A; Iwersen-Bergmann S
Drug Test Anal; 2011 Sep; 3(9):560-8. PubMed ID: 21381220
[TBL] [Abstract][Full Text] [Related]
31. Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands.
van Amsterdam JG; van Laar M; Brunt TM; van den Brink W
Regul Toxicol Pharmacol; 2012 Jun; 63(1):55-63. PubMed ID: 22440552
[TBL] [Abstract][Full Text] [Related]
32. Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review.
Caputo F; Vignoli T; Maremmani I; Bernardi M; Zoli G
Int J Environ Res Public Health; 2009 Jun; 6(6):1917-29. PubMed ID: 19578468
[TBL] [Abstract][Full Text] [Related]
33. The Intensive Treatment Unit: A brief inpatient detoxification facility demonstrating good postdetoxification treatment entry.
Carroll CP; Triplett PT; Mondimore FM
J Subst Abuse Treat; 2009 Sep; 37(2):111-9. PubMed ID: 19150200
[TBL] [Abstract][Full Text] [Related]
34. Healthcare professionals' regard towards working with patients with substance use disorders: comparison of primary care, general psychiatry and specialist addiction services.
van Boekel LC; Brouwers EPM; van Weeghel J; Garretsen HFL
Drug Alcohol Depend; 2014 Jan; 134():92-98. PubMed ID: 24099970
[TBL] [Abstract][Full Text] [Related]
35. GHB: a life-threatening drug complications and outcome of GHB detoxification treatment-an observational clinical study.
Neu P; Danker-Hopfe H; Fisher R; Ehlen F
Addict Sci Clin Pract; 2023 Oct; 18(1):62. PubMed ID: 37864267
[TBL] [Abstract][Full Text] [Related]
36. A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration.
Addolorato G; Caputo F; Capristo E; Bernardi M; Stefanini GF; Gasbarrini G
Clin Neuropharmacol; 1999; 22(1):60-2. PubMed ID: 10047936
[TBL] [Abstract][Full Text] [Related]
37. Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats.
Carai MA; Quang LS; Atzeri S; Lobina C; Maccioni P; Orrù A; Gessa GL; Maher TJ; Colombo G
Brain Res Brain Res Protoc; 2005 Jul; 15(2):75-8. PubMed ID: 15886053
[TBL] [Abstract][Full Text] [Related]
38. [Gamma-hydroxybutyric acid (GHB): more than a date rape drug, a potentially addictive drug].
Karila L; Novarin J; Megarbane B; Cottencin O; Dally S; Lowenstein W; Reynaud M
Presse Med; 2009 Oct; 38(10):1526-38. PubMed ID: 19762202
[TBL] [Abstract][Full Text] [Related]
39. A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia.
Kantrowitz JT; Citrome L; Javitt DC
Clin Ther; 2009 Jun; 31 Pt 1():1360-73. PubMed ID: 19698899
[TBL] [Abstract][Full Text] [Related]
40. Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: what to do?
van Mechelen JC; Dijkstra B; Vergouwen A
BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31796453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
